The NIDDK Disorders of Gastrointestinal Interoception Consortium Clinical Centers (DGIC)
This grant funds a consortium to study how the nervous system’s sensing of the gut affects GI disorders in adults and children, expanding research beyond gastroparesis to identify mechanisms, biomarkers, and new treatments.
Funder: National Institutes of Health (NIH)
Due Dates: November 1, 2026 (Estimated)
Funding Amounts: Estimated total program funding: $1,500,000; 1 award expected; funding duration and ceiling not specified.
Summary: Supports a consortium to investigate mechanisms and therapeutic targets in gastrointestinal interoception disorders, expanding beyond gastroparesis to related GI conditions.
Key Information: Forecasted opportunity; details and deadlines may change—check program page for updates.
Description
This opportunity, issued by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), aims to establish a Disorders of Gastrointestinal Interoception Consortium (DGIC). Building on the work of the Gastroparesis Consortium, this initiative will expand research to include a broad range of adult and pediatric gastrointestinal (GI) disorders characterized by impaired interoceptive processing. The consortium is intended to foster multidisciplinary research that clarifies the mechanisms linking GI function to symptoms, identifies biomarkers for disease and treatment response, and leverages new technologies to find novel therapeutic targets. The DGIC will likely consist of up to six Clinical Research Centers and a Scientific Data Research Center (SDRC), which will coordinate collaborations, participant enrollment, biospecimen processing, and data management.
